Adults 18 to 60, female only, with Alcohol Abuse or Tobacco Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Days Per Month of Primary Substance UsePrimary· 7 non-overlapping monthly intervals from baseline to month 6
Participants completed a timeline followback at each assessment, reporting days of primary substance use. Outcomes reported are raw means and standard deviations.
baseline
Group
Value
95% CI
Motivational Interview-Nurse
23.2
± 8.3
Motivational Interview-Computer
23.7
± 7.7
Treatment as Usual
24.2
± 7.7
Month 1
Group
Value
95% CI
Motivational Interview-Nurse
19.3
± 11.2
Motivational Interview-Computer
19.7
± 11.2
Treatment as Usual
22.8
± 8.9
Month 2
Group
Value
95% CI
Motivational Interview-Nurse
18.7
± 11.8
Motivational Interview-Computer
17.9
± 12.1
Treatment as Usual
22.2
± 10.1
Month 3
Group
Value
95% CI
Motivational Interview-Nurse
18.0
± 12.0
Motivational Interview-Computer
17.8
± 11.9
Treatment as Usual
21.4
± 10.6
Month 4
Group
Value
95% CI
Motivational Interview-Nurse
18.0
± 12.2
Motivational Interview-Computer
16.8
± 12.3
Treatment as Usual
20.0
± 11.4
Month 5
Group
Value
95% CI
Motivational Interview-Nurse
17.6
± 12.5
Motivational Interview-Computer
16.3
± 12.6
Treatment as Usual
19.7
± 11.4
Month 6
Group
Value
95% CI
Motivational Interview-Nurse
17.0
± 12.3
Motivational Interview-Computer
16.2
± 12.5
Treatment as Usual
19.1
± 11.8
Treatment UtilizationPrimary· baseline to 6 months
Treatment utilization assessed via participant self-report at each follow-up interview, and with the exception of self-help groups, verified with providers. We also reviewed the medical record for use of medication indicative of treatment (e.g., nicotine replacement therapy).
utilized treatment
Group
Value
95% CI
Motivational Interview-Nurse
39
Motivational Interview-Computer
39
Treatment as Usual
43
no tretment
Group
Value
95% CI
Motivational Interview-Nurse
106
Motivational Interview-Computer
104
Treatment as Usual
108
Rates of STDsSecondary· baseline to 6 months
rates of incident std's per patient's medical records
Incident case
Group
Value
95% CI
Motivational Interview-Nurse
8
Motivational Interview-Computer
4
Treatment as Usual
6
Non-incident case
Group
Value
95% CI
Motivational Interview-Nurse
135
Motivational Interview-Computer
138
Treatment as Usual
152
Missing
Group
Value
95% CI
Motivational Interview-Nurse
2
Motivational Interview-Computer
1
Treatment as Usual
3
Mean Cost for Each InterventionSecondary· 6 months
The data table includes the mean cost for implementation of each intervention from the societal perspective. The costs do not include the research costs
Group
Value
95% CI
Motivational Interview
57.56
± 16.12
Motivational Interview-Electronic
21.07
± 4.43
Treatment as Usual
21.21
± 7.3
Sponsor's own description
The investigators propose to use obstetric-gynecological clinics to conduct a randomized clinical trial that would compare two SBIRTS (Screening, Brief Intervention, Referral and Treatment), delivered either by a trained nurse or by computer, to usual care (a control condition). As part of this trial, the investigators will include outcomes that allow us to assess the cost effectiveness of these three conditions.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06656013 — Motivational Interview and Nomophobia
· NA
· completed
NCT06195007 — Motivational Interviewing for Stroke
· NA
· terminated
NCT06181890 — The Effect of Motivational Interviews
· unknown
NCT06348628 — Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
· NA
· completed
NCT05646329 — The Effect of Motivational Interviewing on Problematic Internet Use and Loneliness
· NA
· unknown
Other recruiting trials for Alcohol Abuse
Currently open trials in the same condition.
NCT07281261 — tAN for Substance Use Disorder
· NA
· recruiting
NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use
· NA
· recruiting
NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
· NA
· recruiting
NCT05743699 — Adaptation and Evaluation of Bright Horizons
· NA
· recruiting
NCT06265506 — Virtual Incentive Treatment for Alcohol
· NA
· recruiting
Other Yale University trials
Trials by the same sponsor.
NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking
· Phase 2
· not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing
· NA
· not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S
· NA
· not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa
· Phase 1, PHASE2
· not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 14 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01539525.